Team - HotSpot Therapeutics
Having successfully developed hotspot regulatory binders at other biotechnology companies, our co-founders recognized the opportunity to advance this modality by designing a purposeful and systematic approach to finding and targeting regulatory hotspots. We’ve assembled an incredible team of scientists and industry experts with a strong track record of bringing new thinking to complex drug discovery challenges.
Management
Jonathan Montagu
Co-Founder and Chief Executive Officer
Biography
Geraldine Harriman, PhD
Co-Founder and Chief Scientific Officer
Biography
Eva Jack
Chief Operating Officer
Biography
Joe Wahle, PhD
Senior Vice President, Head of Research and Early Translation
Biography
Andrew Morton
Senior Vice President, Finance
Biography
Niti Goel, MD
Senior Clinical Advisor
Biography
Board of Directors
Fouad Azzam, PhD
Director
Biography
Bruce Booth, PhD
Chairman
Biography
Jose “Pepe” Carmona
Director
Biography
Jill Carroll
Director
Biography
Tony Ho, MD
Director
Biography
Jonathan Montagu
Co-Founder and Chief Executive Officer
Biography
Victoria Richon, PhD
Director
Biography
Graziano Seghezzi
Director
Biography
Loretta Tse, PhD
Director
Biography
Clinical Advisors
Aurelien Marabelle, MD, PhD
Institute Gustave Roussy (France)
Background
Ignacio ’Nacho’ Melero, MD, PhD
University of Navarro (Spain)
Background
Scientific Experts
Robert Lewis, PhD
Consulting Professor, Stanford University School of Medicine
Jonathan Mason, PhD
Senior Research Fellow, Heptares Therapeutics
Iain Kilty, PhD
CSO, Sitryx
Anthony Coyle, PhD
President & Head of R&D, Repertoire Immune Medicines
Shawn Rose, MD, PhD
CMO & Head of R&D, Nkarta Therapeutics